Business
CSL (ASX:CSL) share price remains near 52-week low on COVID-19 vaccine delays
The CSL Limited (ASX: CSL) share price is failing to make a meaningful comeback after spending months moving sideways. The global biotech’s shares finished yesterday market session at $263.60, just 8% above its 52-week low reached in early March. At the time of writing, the CSL share price is up slightly, trading for $263.69.
Below, we take a closer look at what could be weighing down CSL shares.
COVID-19 vaccine delay
While most of the world looks towards advancing past the COVID-19 pandemic, Australia has been locked in vaccine holdups. This comes after a reported 2.5 million AstraZeneca doses are being kept in cold storage…
-
General22 hours agoMore buses without dedicated lanes likely after Gold Coast light rail plan scrapped
-
Noosa News23 hours agoStolen truck chase ends in arrest after chaotic three-hour pursuit from Brisbane to Tiaro
-
Noosa News20 hours agoBrisbane kindergarten thrown into chaos amid bitter dispute
-
Noosa News23 hours agoCrocodile Hunter’s father calls for influencer’s deportation over wildlife stunts